Vaccine Roundup

A roundup of the most important Covid-19 vaccine news this week — There are still 20 vaccines in phase 3 trials, six approved for limited use, and four approved for full use in some countries after fully completing phase 3 trials. The fully approved vaccines include those from Pfizer/BioNTech, Sinopharm, Sinovac, and Moderna. Others, including the vaccines from AstraZeneca and Russia’s Sputnik…

A roundup of the most important Covid-19 vaccine news this week — There are now 20 vaccines in phase 3 trials, six approved for limited use, and four approved for full use in some countries after fully completing phase 3 trials — one more vaccine than last week. The fully approved vaccines include those from Pfizer/BioNTech, Sinopharm, and Moderna, and this week…

A roundup of the most important Covid-19 vaccine news this week — There are now 20 vaccines in phase 3 trials, seven approved for limited use, and three approved for full use in some countries after fully completing phase 3 trials: the vaccines from Pfizer/BioNTech, Sinopharm, and Moderna. Others, including that from AstraZeneca, have been approved for emergency use in several countries…

A roundup of the most important Covid-19 vaccine news this week — There are still 20 vaccines in phase 3 trials, eight approved for limited use, and two approved for full use in some countries after fully completing phase 3 trials — the vaccines from Pfizer/BioNTech and Sinopharm. (Those from Moderna and Oxford-AstraZeneca are being used with emergency use approval in some…

A roundup of the most important Covid-19 vaccine news this week — There are now 20 vaccines in phase 3 trials, eight approved for limited use, and two approved for full use in some countries after fully completing phase 3 trials — the vaccines from Pfizer-BioNTech and Sinopharm. …

A roundup of the most important Covid-19 vaccine news this week — There are now 20 vaccines in phase 3 trials, eight approved for limited use, and two approved for full use in some countries after fully completing phase 3 trials: the vaccines from Pfizer/BioNTech and Sinopharm. (Those from Moderna and Oxford/AstraZeneca are being used with emergency use approval in some countries.) …